Cridanimod sodium
Product Specifications
CAS Number
58880-43-6
Target
Others, IFNAR
Related Pathways
Others, Immunology/Inflammation
Bioactivity
Cridanimod can increase progesterone receptor (PR) expression, with potential antineoplastic adjuvant activity. Cridanimod is able to induce the expression of PR in endometrial cancer. In combination with a progestin, cancer cells could be eradicated through increased PR-mediated signaling, leading to an inhibition of luteinizing hormone release from the pituitary gland, via a negative feedback mechanism, and, eventually, an inhibition of estrogen released from the ovaries.
Smiles
[Na+].[O-]C(=O)CN1C2=C(C=CC=C2)C(=O)C2=C1C=CC=C2
Molecular Formula
C15H11NNaO3
Molecular Weight
276.24
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15210227 1 Vial
Lentiviral mouse Gabpa shRNA (UAS) - Lentiviral mouse Gabpa shRNA (UAS, RFP) (25)
Sign In for Pricing
View Details 
GTR15258369 1 Vial
Lentiviral mouse Sec11c shRNA (UAS) - Lentiviral mouse Sec11c shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details